Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
200 mg | Warenkorb auf Verfügbarkeit prüfen | € 407,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
sodium phenylbutyrate
manufacturer/tradename
USP
application(s)
pharmaceutical
pharmaceutical (small molecule)
pharmaceutical
format
neat
storage temp.
2-8°C
SMILES string
[Na+].[O-]C(=O)CCCc1ccccc1
InChI
1S/C10H12O2.Na/c11-10(12)8-4-7-9-5-2-1-3-6-9;/h1-3,5-6H,4,7-8H2,(H,11,12);/q;+1/p-1
InChI key
VPZRWNZGLKXFOE-UHFFFAOYSA-M
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Sodium Phenylbutyrate Oral Powder
- Sodium Phenylbutyrate Tablets
Biochem/physiol Actions
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description pharmaceutical secondary standard, certified reference material | description ≥98% (HPLC) | description A novel anti-neoplastic agent and transcriptional regulator. |
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename - | manufacturer/tradename Calbiochem® |
| grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade - | grade - |
| format neat | format - | format - | format - |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical | application(s) - | application(s) - |
| API family sodium phenylbutyrate | API family sodium phenylbutyrate | API family - | API family - |
| agency USP | agency traceable to USP 1614512 | agency - | agency - |
Still not finding the right product?
Explore all of our products under 4-Phenylbuttersäure Natriumsalz
Lagerklasse
11 - Combustible Solids
Was ist los?
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

